CreakyJoints Finds Lack of Research Stymies Uptake of Evidenced Based Prescribing of Medical Marijuana for Pain Associated with Rheumatic Conditions
Retrieved on:
Monday, May 2, 2022
Pharmaceutical, Alternative Medicine, General Health, Health, Tobacco, Clinical Trials, Retail, Other Health, UCLA School of Dentistry, Rheumatism, Pain, Cedars-Sinai Medical Center, Mouse, Cannabis, Dizziness, Food and Drug Administration, Physician, Food, Cannabinoid, Injury, CA, Network, Patient, Doctor of Philosophy, Partnership, Review, Caregiver, Literature, FDA, Inflammation, Human, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Rheumatology, MD, FACP, OMC, Conditional sentence, Arthritis, Method, Disease, Education, RATS, Medical director, Research, Cell, Social media, Medical device, Pharmaceutical industry, Dietary supplement, Medicine
The article, Cannabis for rheumatic disease pain: A review of current literature , published in the latest issue of Current Rheumatology Reports.
Key Points:
- The article, Cannabis for rheumatic disease pain: A review of current literature , published in the latest issue of Current Rheumatology Reports.
- In addition, studies in humans that support efficacy are primarily surveys of people using medicinal marijuana who report relief of pain.
- Recognize some individuals may have symptomatic relief with medicinal cannabis, but educate patients about the lack of clinical research.
- Support the urgent need for further research regarding the effects of medical cannabis in rheumatic disease.